A recent retrospective study (MA Sheiko et al JPGN 2017; 65: 80-5) examines the issue of azathioprine (AZA) metabolites and outcomes in pediatric autoimmune hepatitis (AIH).
- 66 children
- Mean age of diagnosis 9.6 years
- Mean follow-up 2.9 years
- Study period 2002-2013
- 79% achieved biochemical remission (defined as ALT ≤50 U/L); mean time was 6.2 months
- 6% required liver transplantation
- 18% were weaned off immunosuppression and remained in remission
- 6-thioguanine (6-TGN) levels ranging from 50 to 250 (pmol/8 x 10 to 8th red blood cell count) were associated with biochemical remission
“Our study suggests that AZA dosing of approximately 1.2 to 1.6 mg/kg/day will achieve 6-TGN levels of 50 to 250 pmol, which is sufficient to maintain biochemical remission in the majority of patients.“
This is significantly lower than dosing recommended for inflammatory bowel disease (recommended levels 250-450). The associated editorial (pg 2-3, N Kerkar) cautions that while “lower levels are sufficient for maintaining biochemical remission…higher levels, similar to that used in IBD, are required for inducing remission.”
My take: Lower doses of azathioprine are likely to maintain biochemical remission and cause fewer side effects. Metabolite levels can be helpful to assure reasonable levels of 6-TGN and to assure medication adherence.
Related blog entries:
- Azathioprine metabolite measurement in Autoimmune Hepatitis
- Adult versus Pediatric Data: Autoimmune Hepatitis
- Diagnosing autoimmune hepatitis
- Withdrawing immunosuppression with autoimmune hepatitis
- Liver Problems with Inflammatory Bowel Disease
- Staying current with PSC | gutsandgrowth
Disclaimer: These blog posts are for educational purposes only. Specific dosing of medications (along with potential adverse effects) should be confirmed by prescribing physician. This content is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a condition.